Article info

Download PDFPDF

Third cranial nerve palsy in an 88-year-old man after SARS-CoV-2 mRNA vaccination: change of injection site and type of vaccine resulted in an uneventful second dose with humoral immune response

Authors

  • Maria Pia Cicalese San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Hospital, Milan, ItalyPediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Hospital, Milan, Italy PubMed articlesGoogle scholar articles
  • Francesca Ferrua San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Hospital, Milan, ItalyPediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Hospital, Milan, Italy PubMed articlesGoogle scholar articles
  • Federica Barzaghi San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Hospital, Milan, ItalyPediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Hospital, Milan, Italy PubMed articlesGoogle scholar articles
  • Federica Cerri Division of Neuroscience and Department of Neurology, IRCCS San Raffaele Hospital, Milan, Italy PubMed articlesGoogle scholar articles
  • Matteo Moro Infection Control Committee, IRCCS San Raffaele Hospital, Milan, Italy PubMed articlesGoogle scholar articles
  • Alessandro Aiuti San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Hospital, Milan, ItalyPediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Hospital, Milan, ItalyVita-Salute San Raffaele University, Milan, Italy PubMed articlesGoogle scholar articles
  • Paolo Silvani Department of Anesthesia and Intensive Care, IRCCS San Raffaele Hospital, Milan, Italy PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Alessandro Aiuti; aiuti.alessandro{at}hsr.it
View Full Text

Citation

Cicalese MP, Ferrua F, Barzaghi F, et al
Third cranial nerve palsy in an 88-year-old man after SARS-CoV-2 mRNA vaccination: change of injection site and type of vaccine resulted in an uneventful second dose with humoral immune response

Publication history

  • Accepted December 26, 2021
  • First published February 8, 2022.
Online issue publication 
February 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.